ABM Industries (NYSE:ABM) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.77 by 2.6 percent. This is a 15.96 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $1.99 billion which missed the analyst consensus estimate of $2.02 billion by 1.42 percent. This is a 2.86 percent increase over sales of $1.94 billion the same period last year.
Earnings Preview For Revance Therapeutics
Revance Therapeutics (NASDAQ:RVNC) is set to give its latest quarterly earnings report on Tuesday, 2023-05-09. Here’s what investors…